Frequency of ERBB2-Low Expression in Endometrial Cancer
This study reanalyzes epidermal growth factor receptor 2 (ERBB2) data from a previous study to characterize patient subgroups with ERBB2-low tumors.
Authors
- Camilla Krakstad (ORCID: https://orcid.org/0000-0002-0174-8139)
- Kristina Lindemann (ORCID: https://orcid.org/0000-0002-2162-0175)
- Mari K. Halle (ORCID: https://orcid.org/0000-0002-2660-8271)
- Hege F. Berg (ORCID: https://orcid.org/0000-0002-1712-6609)
Institutions
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Haukeland University Hospital (NO)
- University of Bergen (NO)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1001/jamaoncol.2024.3660
- Citations
- 4
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Universitetet i Bergen
- Norges Forskningsråd